Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin with AC-TG chemotherapy in HER2-negative breast cancer
NCT00679029Phase 2Terminated
- Sponsor
- University of Nebraska
- Start
- May 2008
- Primary completion
- Nov 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by University of Nebraska. Started May 2008; status: terminated.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00679029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679029.